Increasing Prevalence of Chronic Diseases to Boost Global Electrical Stimulation Devices Market

Published By : 28 Mar 2016 | Published By : QYRESEARCH

The global market for electrical stimulation devices has been witnessing an exponential surge in its valuation. The augmenting prevalence of chronic diseases and medical conditions are propelling this market substantially. Additionally, the introduction of innovative devices as well as novel technologies is likely to boost the worldwide electrical stimulation devices market in the coming years.

Asia Pacific to Lead Global Electrical Stimulation Devices Market
Over the last few years, North America led the global market for electrical stimulation devices. The rising prevalence of sports injuries as well as other lifestyle-related disorders, increasing access to healthcare, and augmenting incidence of pain indications in the aging population have boosted the North America electrical stimulation devices market. Asia Pacific, however, is likely to report the highest growth among all the regional markets for electrical stimulation devices in the forthcoming years.

The rising base of geriatric population in Asia Pacific, together with the increasing disposable income of people and the escalating demand for highly advanced medical interventions, is likely to drive the growth of Asia Pacific electrical stimulation devices significantly in the near future. The North America electrical stimulation devices market is dominated by the U.S. while China leads the Asia Pacific market for electrical stimulation devices.

Introduction of Advanced Devices Drives Europe Electrical Stimulation Devices Market
Europe has also been exhibiting significant growth in the worldwide electrical stimulation devices sing last few years. The introduction of advanced devices by major market players, coupled with the increasing incidence of diabetes, chronic back pain, and injuries (accidental, occupational, or sports), is the key factor driving the Europe electrical stimulation devices market. The U.K., France, and Germany are the major domestic markets for electrical stimulation devices in Europe.

Zynex Inc., Uroplasty Inc., St. Jude Medical Inc., NeuroMetrix Inc., Nevro Corp., Medtronic Plc, DJO Global Inc., Cyberonics Inc., BTL Industries Inc., and Boston Scientific Corp. are some of the leading manufacturers of electric stimulation devices in the global market.

Back To Top